Over the last 40+ years, Ora has been at the forefront of supporting our customers in developing innovative products for the treatment of ocular surface disease.
We are driven to bring better research models to you, providing you with better, clearer data. The team at Ora has been instrumental in partnering with our customers to achieve 52 product approvals over the years, and has most recently supported 2 recent approvals in the treatment of dry eye disease. Our team of allergy experts has supported the clinical development of 17 anti-allergic agents for the treatment of conjunctivitis. Our experience in both experiential and environmental trials will help bring your product to market. Let’s talk about how we can successfully run your next trial!